Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1972 Jan;23(1):4–7. doi: 10.1128/am.23.1.4-7.1972

Evaluation of the In Vitro Activity of Tobramycin as Compared with That of Gentamicin Sulfate

Walter H Traub 1, Ella A Raymond 1
PMCID: PMC380267  PMID: 4621796

Abstract

The in vitro activity of tobramycin was quantitatively compared with that of gentamicin sulfate against 195 bacterial isolates from clinical material. Tobramycin was found to be twice as active as gentamicin against isolates of Pseudomonas aeruginosa. Conversely, gentamicin proved fourfold more active than tobramycin against isolates of Serratia marcescens. Both drugs were of comparable activity against isolates of Staphylococcus aureus and the majority of the enterobacterial isolates other than S. marcescens. On the basis of the obtained data, the following criteria are proposed for the interpretation of diffusion susceptibility tests with 10-μg discs of gentamicin and tobramycin. Enterobacteriaceae and isolates of S. aureus are designated as susceptible to gentamicin and tobramycin if the zones of inhibition measure 15 mm or more in diameter; zones of 14 mm or less are indicative of resistance. Pseudomonadaceae are interpreted as sensitive to tobramycin and gentamicin if the inhibition zones measure at least 15 and 12 mm in diameter, respectively.

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Kirby W. M., Standiford H. C. Gentamicin: in vitro studies. J Infect Dis. 1969 Apr-May;119(4):361–363. doi: 10.1093/infdis/119.4-5.361. [DOI] [PubMed] [Google Scholar]
  3. Matsen J. M., Koepcke M. J., Quie P. G. Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrob Agents Chemother (Bethesda) 1969;9:445–453. [PubMed] [Google Scholar]
  4. Preston D. A., Wick W. E. Preclinical assessment of the antibacterial activity of nebramycin factor 6. Antimicrob Agents Chemother (Bethesda) 1970;10:322–327. doi: 10.1128/AAC.10.2.322. [DOI] [PubMed] [Google Scholar]
  5. Raymond E. A., Traub W. H. Identification of staphylococci isolated from clinical material. Appl Microbiol. 1970 Jun;19(6):919–922. doi: 10.1128/am.19.6.919-922.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Traub W. H., Craddock M. E., Raymond E. A., Fox M., McCall C. E. Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol. 1971 Sep;22(3):278–283. doi: 10.1128/am.22.3.278-283.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Traub W. H., Raymond E. A., Linehan J. Identification of Enterobacteriaceae in the clinical microbiology laboratory. Appl Microbiol. 1970 Sep;20(3):303–308. doi: 10.1128/am.20.3.303-308.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Traub W. H., Raymond E. A. Susceptibility of Pseudomonas aeruginosa to carbenicillin. Appl Microbiol. 1970 Oct;20(4):630–632. doi: 10.1128/am.20.4.630-632.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Traub W. H. Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data. Appl Microbiol. 1970 Jul;20(1):98–102. doi: 10.1128/am.20.1.98-102.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wick W. E., Welles J. S. Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation. Antimicrob Agents Chemother (Bethesda) 1967;7:341–348. doi: 10.1128/AAC.7.3.341. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES